SNAPSHOT: Endoscopic And Pelvic Surgery Devices Market Driven By Innovation, Patient Demand
The global market for endoscopic general and pelvic surgery devices is expected to increase at a CAGR of 5.7%, reaching an estimated $15.8bn in 2021. The major growth driver will be conversion from open to endoscopic surgery and related technological advancements, including better cameras producing brighter, more detailed images and small-diameter devices. The introduction of robotic surgery has been pivotal in expanding the range of procedures, including gastric procedures such as bariatric surgery, which are expected to demonstrate the highest growth during the forecast period (2016-2021), according to a new report by Meddevicetracker.
You may also be interested in...
US FDA usually recommends using overall survival for pancreatic cancer drugs, but AstraZeneca choose progression-free survival; now ODAC will weigh in on whether the PARP inhibitor olaparib demonstrated a clinically meaningful impact. The firm cites enrollment and design challenges in the gBRCAm population as reasons for using PFS.
Attorneys say Sarepta did not have an obligation to report its appeal, particularly since winning a formal dispute filing with the US FDA is a long shot.